NAMS

NewAmsterdam Pharma Co N.V.

CIK 0001936258 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$35.92

↑ 0.09 (0.25%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Options; Risks: Fundamentals

Key stats

Market Cap

$4.20B

P/E Ratio

-19.74

EPS

-1.72

Dividend Yield

Not covered

52W Position

71%

Beta

1.22

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

6.31

P/S

186.09

EV/Revenue

165.81

ROE

-32.0%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 71%

$20.20$42.20

Latest Financials

2025-12-31 FY

Revenue

$22.50M

Net Income

-$203.82M

Total Assets

$769.28M

Free Cash Flow

–

NAMS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

NAMS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news